Liang 2002.

Methods	Design: parallel RCT Randomisation method: not reported Blinding: no Power calculation: no Dropouts/withdrawals: no
Participants	Cancer patients receiving chemotherapy Number (treatment/control): 72 (36/36) Mean age (range): not reported Gender (M/F): not reported Country: Shandong province, China Setting: hospital
Interventions	Moxa stick vs no treatment Treatment group Moxa stick Moxa stick on the bilateral acupoints ST36 (zusanli) and RN12 (zhongwan), 15 minutes, once per day Treatment duration: 14 days (beginning at the same day of chemotherapy) Chemotherapy Control group Chemotherapy
Outcomes	Leukocytes (WHO grade 3 to 4) at the end of treatment
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Not described
Allocation concealment (selection bias)	Unclear risk	No relevant description
Incomplete outcome data (attrition bias) All outcomes	Low risk	There was no loss to follow‐up. All participants were included in the analysis.
Selective reporting (reporting bias)	Unclear risk	Limited outcome measures were reported.
Other bias	Unclear risk	There was no statement about group similarity.
Blinding of participants and personnel (performance bias) All outcomes	High risk	No blinding
Blinding of outcome assessment (detection bias) Subjective outcomes	Unclear risk	No subjective outcome was reported.
Blinding of outcome assessment (detection bias) Objective outcomes	Low risk	No blinding; however, machine‐measured objective outcomes were not influenced substantially